• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Research reveals artificial thyroid cancer epidemic

Bioengineer by Bioengineer
September 7, 2016
in Cancer
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Research led by The Australian National University (ANU) has found doctors around the world are over diagnosing the most common thyroid cancer, creating an artificial epidemic that costs billions of dollars each year in unnecessary medical costs.

Lead researcher Associate Professor Suhail Doi said diagnoses of differentiated thyroid cancer globally had increased three-fold during the past 25 years despite no change to the disease’s low death rate.

“Overly meticulous examinations are detecting the condition in the early stages and resulting in unnecessary surgeries,” said Dr Doi, a clinical epidemiologist at the ANU Research School of Population Health.

“Active monitoring rather than intervention is appropriate in many cases, similar to how doctors treat prostate cancer today,” said Dr Doi, who is also an endocrinologist.

He said differentiated thyroid cancer mainly involves papillary and follicular tumours that don’t usually progress to clinical forms of cancer.

Around 2,500 new cases of differentiated thyroid cancer will be diagnosed in Australia this year.

Thyroid cancer surgery has substantial consequences for patients. Most patients must receive lifelong thyroid-replacement therapy, and some have complications from the procedure, including damage to nerves and surrounding glands.

Dr Doi said the research findings, published in the Journal of Clinical Oncology, would inform clinical guidelines around the world on appropriate treatment for differentiated thyroid cancer, and also help to educate the public about the condition.

“People with this type of thyroid cancer can sometimes live until normal life expectancy and usually die from other causes, so there is no point intervening if the cancer is acting in a benign way and not causing any problems,” Dr Doi said.

“Only some of these cases require treatment if and when the condition progresses to clinical forms of cancer.”

In 2019, the projected medical care costs for differentiated thyroid cancer in United States is estimated to be more than US$3 billion.

“The medical costs for differentiated thyroid cancer in Australia could be about $US300 million in 2019, if we extrapolate from the US projection,” Dr Doi said.

Dr Doi and his colleagues analysed international autopsy data, including from regions that had high and low instances of differentiated thyroid cancer, over six decades from the 1960s.

They found that incidental differentiated thyroid cancer has remained unchanged, confirming for the first time that the epidemic has been driven by increasing detections of cancer.

“Ultimately, this research will help improve thyroid cancer patients’ quality of life and reduce avoidable burden on health systems.”

###

Other co-authors of this study are ANU PhD student Luis Furuya-Kanamori, Dr Katy Bell from University of Sydney, and Justin Clark and Professor Paul Glasziou at Bond University.

Global trends:

  • In Australia, during 1982-2012, diagnoses of differentiated thyroid cancer increase 3 times in women and 2 times in men (Source: Cancer Australia).
  • In the United States, during 1975-2013, diagnoses of differentiated thyroid cancer increased 3 times (Source: US National Cancer Institute).
  • In Canada, during 1986-2015, diagnoses of differentiated thyroid cancer increased 4.5 times in women and 3 times in men (Source: Canadian Cancer Society).
  • In the United Kingdom, during 1979-2013, diagnoses of differentiated thyroid cancer increased 3 times (Source: Cancer Research UK).
  • In South Korea, during 1993-2011, diagnoses of differentiated thyroid cancer increased 15 times (Source: Korean Central Cancer Registry).

FOR INTERVIEW:

Associate Professor Suhail Doi
ANU Research School of Population Health
T: +974 6600 1271 (can be contacted before 3pm or after 9pm AEST)
E: [email protected]

Dr Luis Furuya-Kanamori
ANU Research School of Population Health
M: +61 487 448 584
E: [email protected]

FOR MEDIA ASSISTANCE:

Will Wright
T: +61 2 6125 7979
M: +61 478 337 740
E: [email protected]

Media Contact

Suhail Doi
[email protected]
974-660-01271
@ANUmedia

http://www.anu.edu.au/media

The post Research reveals artificial thyroid cancer epidemic appeared first on Scienmag.

Share12Tweet8Share2ShareShareShare2

Related Posts

Preoperative MRI Improves Stage II-III Colon Cancer Outcomes

Preoperative MRI Improves Stage II-III Colon Cancer Outcomes

August 8, 2025
blank

Ultrasound Insights on Hip Dysplasia in Infants

August 8, 2025

Scientists Discover Trigger to Activate Cells’ Self-Cleaning Mechanism

August 8, 2025

Genetic Testing Minimizes Chemotherapy Risks in Gastrointestinal Cancer Patients

August 8, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    78 shares
    Share 31 Tweet 20
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    76 shares
    Share 30 Tweet 19
  • Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    61 shares
    Share 24 Tweet 15
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    52 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Preoperative MRI Improves Stage II-III Colon Cancer Outcomes

Exome Analysis Reveals Genes Behind Kidney Malformations

Ultrasound Insights on Hip Dysplasia in Infants

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.